These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9363836)

  • 21. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Barohn RJ; Saperstein DS
    Semin Neurol; 1998; 18(1):49-61. PubMed ID: 9562667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inflammatory demyelinating polyneuropathy and paraproteinemic neuropathies.
    Glass JD; Cornblath DR
    Curr Opin Neurol; 1994 Oct; 7(5):393-7. PubMed ID: 7804458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing views of Guillain-Barré syndrome.
    Asbury AK; McKhann GM
    Ann Neurol; 1997 Mar; 41(3):287-8. PubMed ID: 9066348
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy.
    Vermeulen M; van Schaik IN; Brand A
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):383-4. PubMed ID: 7897433
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma exchange in immune-mediated neuropathies.
    Lehmann HC; Hartung HP; Meyer Zu Hörste G; Kieseier BC
    Curr Opin Neurol; 2008 Oct; 21(5):547-54. PubMed ID: 18769248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acquired demyelinating neuropathies].
    Hahn AF
    Rev Prat; 2000 Apr; 50(7):724-30. PubMed ID: 10853551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG
    Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
    [No Abstract]   [Full Text] [Related]  

  • 28. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    Van Doorn PA
    Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic immune demyelinating neuropathies.
    Lopate G; Pestronk A
    Semin Neurol; 1994 Jun; 14(2):131-6. PubMed ID: 7527153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent acquisitions in the treatment of chronic immune-mediated polyneuropathies].
    Léger JM; Viala K
    Rev Neurol (Paris); 2004 Feb; 160(2):205-10. PubMed ID: 15034478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Guillain-Barré syndrome; pathogenesis and treatment.
    Van Der Meché FG
    Rev Neurol (Paris); 1996 May; 152(5):355-8. PubMed ID: 8881429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational therapy of Guillain-Barré syndrome.
    Berciano J
    Lancet; 1998 Mar; 351(9104):754-5. PubMed ID: 9504544
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous immunoglobulin therapy in the inflammatory neuropathies.
    Churchyard A; Day T; Grainger K; Mastaglia FL
    Clin Exp Neurol; 1991; 28():168-79. PubMed ID: 1821824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic response of serum from patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Armati PJ; Pollard JD
    Acta Neurol Scand; 1987 Jul; 76(1):24-7. PubMed ID: 3630641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin.
    Nwosu EC; Tandon S; Breeze C; Enevoldson TP; Khaleeli AA
    Br J Obstet Gynaecol; 1999 Feb; 106(2):174-6. PubMed ID: 10426685
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of Guillain-Barré syndrome in adults: role of plasma exchange].
    Raphael JC; Chevret S; Auriant I; Sharshar T; Bouget J; Bolgert F
    Rev Med Interne; 1998 Jan; 19(1):60-8. PubMed ID: 9775118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.